Glycolipid‐activated NKT cells support the induction of persistent plasma cell responses and antibody titers
Open Access
- 7 April 2008
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 38 (4) , 1001-1011
Abstract
NKT cell activation with CD1d‐binding glycolipid α‐galactosylceramide (α‐GC) enhances antibody responses to co‐administered T‐dependent antigen. The efficacy of α‐GC relative to other CD1d‐binding glycolipids and adjuvants is not known. There is little information on how NKT cells affect antibody production beyond initial booster‐stimulated recall responses. We therefore tested the hypothesis that α‐GC stimulates induction of plasma cells and antibody responses as effectively as Th1‐ and Th2‐skewing variants of α‐GC and several other adjuvants. C57BL/6 and CD1d–/– mice were immunized with nitrophenol‐conjugated keyhole limpet hemocyanin (NP‐KLH) plus α‐GC or NP‐KLH plus adjuvants before administration of an NP‐KLH booster and assessing antibody responses and plasma cell frequency. α‐GC boosted long‐term antibody responses as efficiently as all other agents tested and induced plasma cells that were detected in bone marrow 13 weeks after immunization. We then determined whether NKT cells were required in the presence of other adjuvants. CD1d–/– mice had a reduced induction of plasma cells in response to NP‐KLH/Alum as compared to C57BL/6 mice. However, NKT cells were not required for the continued presence of those cells that were induced. Although NKT cells are capable of inducing persistent plasma cell responses, they may not play a major role in supporting longevity post‐induction.Keywords
This publication has 44 references indexed in Scilit:
- Invariant NKT cells sustain specific B cell responses and memoryProceedings of the National Academy of Sciences, 2007
- Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor SignalingScience, 2006
- The CD1d‐binding glycolipid α‐galactosylceramide enhances humoral immunity to T‐dependent and T‐independent antigen in a CD1d‐dependent mannerImmunology, 2006
- Phenotypical and functional alterations during the expansion phase of invariant Vα14 natural killer T (Vα14i NKT) cells in mice primed with α‐galactosylceramideImmunology, 2005
- ANTIGEN-SPECIFIC MEMORY B CELL DEVELOPMENTAnnual Review of Immunology, 2005
- Short-lived Plasmablasts and Long-lived Plasma Cells Contribute to Chronic Humoral Autoimmunity in NZB/W MiceJournal of Experimental Medicine, 2004
- Mechanism of CD1d-restricted natural killer T cell activation during microbial infectionNature Immunology, 2003
- Nonredundant Roles for CD1d-restricted Natural Killer T Cells and Conventional CD4+ T Cells in the Induction of Immunoglobulin E Antibodies in Response to Interleukin 18 Treatment of MiceJournal of Experimental Medicine, 2003
- Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesisEuropean Journal of Immunology, 1999
- THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and GlycolipidsAnnual Review of Immunology, 1999